| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/06/2007 | WO2007138361A2 Chymotripsin from lucilia sericata larvae and its use for the treatment of wounds |
| 12/06/2007 | WO2007138324A2 Materials and complexes for the delivery of biologically-active material to cells |
| 12/06/2007 | WO2007138163A2 Antibodies and standard for nt-probnp and probnp immunoassays |
| 12/06/2007 | WO2007138070A2 Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same |
| 12/06/2007 | WO2007137986A2 Vaccination against cancer |
| 12/06/2007 | WO2007137810A1 Cytokinin receptor variants and their use |
| 12/06/2007 | WO2007137591A2 Hiv vaccine |
| 12/06/2007 | WO2007137586A2 Random insertion of peptides |
| 12/06/2007 | WO2007137328A1 An isolated il-12 molecule or chimeric molecules thereof |
| 12/06/2007 | WO2007112953A8 Process for the purification of recombinant alpha 1-antitrypsin involving a step of anion exchange chromatography |
| 12/06/2007 | WO2007102946A3 Crystalline polypeptides |
| 12/06/2007 | WO2007098257A3 Hiv tev compositions and methods of use |
| 12/06/2007 | WO2007075439A3 Compositions and methods for treating obesity and related metabolic disorders |
| 12/06/2007 | WO2007059221A3 Hepatitis c virus variants |
| 12/06/2007 | WO2007035382A3 Acaricidal compositions and methods of use thereof |
| 12/06/2007 | WO2007002534A3 Thrombospondin-1 derived peptides and treatment methods |
| 12/06/2007 | WO2006110728A3 Immunogenic cmv tegument aggregates |
| 12/06/2007 | WO2006083853A3 Methods of identification of biomarkers with mass spectrometry techniques |
| 12/06/2007 | WO2005080436A3 Antibodies that bind pote and uses thereof |
| 12/06/2007 | WO2005072254A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 12/06/2007 | WO2005072141A3 Peptide inhibitors of rhoa signaling |
| 12/06/2007 | WO2005047850A3 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 12/06/2007 | WO2005027854A3 T cell regulatory genes associated with immune disease |
| 12/06/2007 | WO2005017182A3 Multi-color in vitro translation |
| 12/06/2007 | WO2004074460A3 Nucleotide and protein sequences of coc genes and methods based thereon |
| 12/06/2007 | WO2004060304A3 Novel compositions and methods in cancer |
| 12/06/2007 | WO2004052233A3 Canine rankl and methods for preparing and using the same |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070283460 Constructs useful for production of transgenic plants having at least one improved property as the result of expression of the polypeptide; include yield, disease resistance, growth rate, stress tolerance |
| 12/06/2007 | US20070283459 Expressed sequence tags for use in targeting and isolation of genes for plant protection and improvement |
| 12/06/2007 | US20070283452 Injecting potential tumor cells into a transgenic mouse with a nucleic acid genome encoding the extracellular domain of humanized CTLA4 receptor; administering a candidate drug to the mouse; and monitoring tumor growth |
| 12/06/2007 | US20070282015 Novel Splice Variants of Human Dkkl1 |
| 12/06/2007 | US20070281896 Novel compositions and methods in cancer |
| 12/06/2007 | US20070281895 Molecular Marker |
| 12/06/2007 | US20070281890 Fibroblast Growth Factor-13 |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070281887 Isoforms of brain natriuretic peptide |
| 12/06/2007 | US20070281886 Retinal pigmented epithelium derived neurotrophic factor |
| 12/06/2007 | US20070281883 Development of follicle stimulating hormone agonists and antagonists in fish |
| 12/06/2007 | US20070281368 Binding proteins as biosensors |
| 12/06/2007 | US20070281365 Crystal Structure of Erbb2 and Uses Thereof |
| 12/06/2007 | US20070281363 Luminescent compounds |
| 12/06/2007 | US20070281334 Methods and materials for increasing expression of recombinant polypeptides |
| 12/06/2007 | US20070281333 Metal-binding motif compositions and methods |
| 12/06/2007 | US20070281329 Characterization of individual polymer molecules based on monomer-interface interactions |
| 12/06/2007 | US20070281320 Novel Bioactive Lipid Derivatives, and Methods of Making and Using Same |
| 12/06/2007 | US20070281306 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 12/06/2007 | US20070281302 Peptide ligands for Bacillus anthracis spore detection |
| 12/06/2007 | US20070281006 Methods And Compositions Comprising Supramolecular Constructs |
| 12/06/2007 | US20070280966 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides |
| 12/06/2007 | US20070280962 HBV core antigen particles with multiple immunogenic components attached via peptid ligands |
| 12/06/2007 | US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses |
| 12/06/2007 | US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases |
| 12/06/2007 | US20070280956 Novel hepatitis C virus peptides and uses thereof |
| 12/06/2007 | US20070280938 Peptides Derived from Natural Cytotoxicity Receptors and Methods of Use Thereof |
| 12/06/2007 | US20070280936 Method for treating psoriasis |
| 12/06/2007 | US20070280921 recombinant silicatein- beta and silicatein- beta -fusion proteins from Suberites domuncula |
| 12/06/2007 | US20070280908 Treatment of diabetes with synthetic beta cells |
| 12/06/2007 | US20070280904 Lectin-derived progenitor cell preservation factors and methods of use |
| 12/06/2007 | US20070280903 T1 Receptor-Like Ligand II and Uses Thereof |
| 12/06/2007 | US20070280884 Insect poison allergens with reduced IgE reactivity and method for producing the same |
| 12/06/2007 | US20070280879 Therapeutic Use Of Rm1 Antigen |
| 12/06/2007 | DE102006026591A1 Isoliertes naturidentisches Kollagen The isolated nature-identical collagen |
| 12/06/2007 | CA2653752A1 Ob fold domains |
| 12/06/2007 | CA2653668A1 Novel applications for staphylococcus aureus sbi protein |
| 12/06/2007 | CA2653600A1 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 12/06/2007 | CA2653402A1 Method |
| 12/06/2007 | CA2653080A1 Compositions and methods for the delivery of oxygen |
| 12/06/2007 | CA2652907A1 Compositions and methods for treatment of diabetes |
| 12/06/2007 | CA2652894A1 Genetically encoded fluorescent coumarin amino acids |
| 12/06/2007 | CA2652733A1 Modified humanised anti-interleukin-18 antibodies |
| 12/06/2007 | CA2652506A1 Glycopeptide antibiotic derivative |
| 12/06/2007 | CA2652446A1 Plants having enhanced yield-related traits and a method for making the same |
| 12/06/2007 | CA2651961A1 Manipulation of the nitrogen metabolism |
| 12/06/2007 | CA2651499A1 Methods and compositions for ccr-5 gene inactivation |
| 12/06/2007 | CA2650510A1 Materials and complexes for the delivery of biologically-active material to cells |
| 12/06/2007 | CA2647161A1 Probiotic strain and antimicrobial peptide derived therefrom |
| 12/05/2007 | EP1862626A1 Novel trichoderma genes |
| 12/05/2007 | EP1862553A2 New targets for herbicides and genetically modified plants that are resistant to these herbicides |
| 12/05/2007 | EP1862550A1 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 12/05/2007 | EP1862549A2 Target of RNAIII activating protein (TRAP) |
| 12/05/2007 | EP1862548A1 Death domain containing receptor 4 (DR4 : death receptor 4), member of the TNF-receptor superfamily and binding to trail (APO2-L) |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862540A1 Novel trichoderma genes |
| 12/05/2007 | EP1862539A1 Novel trichoderma genes |
| 12/05/2007 | EP1862476A2 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
| 12/05/2007 | EP1862474A1 Reagent for the diagnosis of rheumatoid arthritis |
| 12/05/2007 | EP1862473A2 Corn root preferential promoters and uses thereof |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862471A2 Pharmacologically active antiviral peptides and methods of their use |
| 12/05/2007 | EP1862178A1 Use of HLTF antibodies for diagnosis and treatment of cancer |
| 12/05/2007 | EP1862174A1 Inhibitor for insulin polymer formation |
| 12/05/2007 | EP1862173A1 Promoter of regeneration of pancreatic cell, and promoter of insulin production in pancreatic cell |
| 12/05/2007 | EP1861498A2 Expression vectors for enhanced transient gene expression and mammalian cells expressing them |
| 12/05/2007 | EP1861493A1 Mutant alleles of the zwf gene (g6pdh) from coryneform bacteria for increasing lysine production |
| 12/05/2007 | EP1861423A1 Molecules and chimeric molecules thereof |
| 12/05/2007 | EP1861422A2 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 12/05/2007 | EP1861421A1 Recombinant expression of defensins in filamentous fungi |